A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A U.K.-based drugmaker recently asked a federal court to strike down Nebraska’s contract pharmacy access law, making it the latest [...] …
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...] …
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...] …